Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium : Impact on Treatment Outcome and Resistance | Zendy

Tim Read | Zendy; Christopher K. Fairley | Zendy; Sepehr N. Tabrizi | Zendy; Melanie Bissessor | Zendy; Lenka A. Vodstrcil | Zendy; Eric P. F. Chow | Zendy; Mieken Grant | Zendy; Jennifer Danielewski | Zendy; Suzanne M. Garland | Zendy; Jane S. Hocking | Zendy; Marcus Y. Chen | Zendy; Catriona S. Bradshaw | Zendy

Open Access

Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium : Impact on Treatment Outcome and Resistance

Author(s) -

Tim Read,

Christopher K. Fairley,

Sepehr N. Tabrizi,

Melanie Bissessor,

Lenka A. Vodstrcil,

Eric P. F. Chow,

Mieken Grant,

Jennifer Danielewski,

Suzanne M. Garland,

Jane S. Hocking,

Marcus Y. Chen,

Catriona S. Bradshaw

Publication year - 2016

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciw719

Subject(s) - mycoplasma genitalium , azithromycin , urethritis , medicine , confidence interval , gastroenterology , microbiology and biotechnology , antibiotics , chlamydia trachomatis , virology , biology

We evaluated the impact of extended azithromycin (1.5g over 5 days) on selection of macrolide resistance and microbiological cure in men with Mycoplasma genitalium urethritis during 2013-2015 and compared this to cases treated with azithromycin 1g in 2012-2013.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research